BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9171249)

  • 1. Persistent postoperative complaints after whole sural nerve biopsies in diabetic and non-diabetic subjects.
    Dahlin LB; Eriksson KF; Sundkvist G
    Diabet Med; 1997 May; 14(5):353-6. PubMed ID: 9171249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative outcomes and reliability of "sensation-sparing" sural nerve biopsy.
    Campbell CA; Turza KC; Morgan RF
    Muscle Nerve; 2009 Oct; 40(4):603-9. PubMed ID: 19760791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequelae following sural nerve biopsy in type 1 diabetic subjects.
    Dahlin LB; Lithner F; Bresäter LE; Thomsen NO; Eriksson KF; Sundkvist G
    Acta Neurol Scand; 2008 Sep; 118(3):193-7. PubMed ID: 18336622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sural nerve biopsy may predict future nerve dysfunction.
    Thrainsdottir S; Malik RA; Rosén I; Jakobsson F; Bakhtadze E; Petersson J; Sundkvist G; Dahlin LB
    Acta Neurol Scand; 2009 Jul; 120(1):38-46. PubMed ID: 19154542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve biopsy.
    Thomas PK
    Diabet Med; 1997 May; 14(5):345-6. PubMed ID: 9171247
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy.
    Ruth A; Schulmeyer FJ; Roesch M; Woertgen C; Brawanski A
    Clin Neurol Neurosurg; 2005 Apr; 107(3):214-7. PubMed ID: 15823677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between fascicular and whole sural nerve biopsy.
    Pollock M; Nukada H; Taylor P; Donaldson I; Carroll G
    Ann Neurol; 1983 Jan; 13(1):65-8. PubMed ID: 6830168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early peripheral nerve abnormalities in impaired glucose tolerance.
    Cappellari A; Airaghi L; Capra R; Ciammola A; Branchi A; Levi Minzi G; Bresolin N
    Electromyogr Clin Neurophysiol; 2005 Jun; 45(4):241-4. PubMed ID: 16083148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test.
    Koçer A; Domaç FM; Boylu E; Us O; Tanridağ T
    Acta Neurol Scand; 2007 Dec; 116(6):399-405. PubMed ID: 17986099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients. Surgical approach and the role of collateral sprouting.
    Theriault M; Dort J; Sutherland G; Zochodne DW
    Neurology; 1998 Feb; 50(2):480-4. PubMed ID: 9484376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in the extent of sensory deficit after sural nerve biopsy.
    Kumar S; Jacob J
    Neurol India; 2004 Dec; 52(4):436-8. PubMed ID: 15626827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of sural nerve biopsy in diabetic versus non-diabetic patients.
    Perry JR; Bril V
    Can J Neurol Sci; 1994 Feb; 21(1):34-7. PubMed ID: 8180902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms.
    Yagihashi S; Yamagishi S; Wada R
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S184-9. PubMed ID: 17462777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance.
    Sundkvist G; Dahlin LB; Nilsson H; Eriksson KF; Lindgärde F; Rosén I; Lattimer SA; Sima AA; Sullivan K; Greene DA
    Diabet Med; 2000 Apr; 17(4):259-68. PubMed ID: 10821291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
    Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
    Haslbeck KM; Schleicher ED; Friess U; Kirchner A; Neundörfer B; Heuss D
    Acta Neuropathol; 2002 Jul; 104(1):45-52. PubMed ID: 12070663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsy of the posterior interosseous nerve: a low morbidity method for assessment of peripheral nerve disorders.
    Thomsen NO; Mojaddidi M; Malik RA; Dahlin LB
    Diabet Med; 2009 Jan; 26(1):100-4. PubMed ID: 19125770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired skin microvascular reactivity in painful diabetic neuropathy.
    Quattrini C; Harris ND; Malik RA; Tesfaye S
    Diabetes Care; 2007 Mar; 30(3):655-9. PubMed ID: 17327336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome.
    Said G; Elgrably F; Lacroix C; Planté V; Talamon C; Adams D; Tager M; Slama G
    Ann Neurol; 1997 Jun; 41(6):762-70. PubMed ID: 9189037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14).
    Hsu WC; Chiu YH; Chen WH; Chiu HC; Liou HH; Chen TH
    Neuroepidemiology; 2007; 28(1):50-5. PubMed ID: 17215587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.